163 related articles for article (PubMed ID: 11160187)
1. Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function.
Yun TJ; Tallquist MD; Aicher A; Rafferty KL; Marshall AJ; Moon JJ; Ewings ME; Mohaupt M; Herring SW; Clark EA
J Immunol; 2001 Feb; 166(3):1482-91. PubMed ID: 11160187
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.
Chagraoui H; Tulliez M; Smayra T; Komura E; Giraudier S; Yun T; Lassau N; Vainchenker W; Wendling F
Blood; 2003 Apr; 101(8):2983-9. PubMed ID: 12506018
[TBL] [Abstract][Full Text] [Related]
3. Immune function of the decoy receptor osteoprotegerin.
Bengtsson AK; Ryan EJ
Crit Rev Immunol; 2002; 22(3):201-15. PubMed ID: 12498383
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss.
Zehnder AF; Kristiansen AG; Adams JC; Kujawa SG; Merchant SN; McKenna MJ
Laryngoscope; 2006 Feb; 116(2):201-6. PubMed ID: 16467704
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
[TBL] [Abstract][Full Text] [Related]
7. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay N; Sarosi I; Dunstan CR; Morony S; Tarpley J; Capparelli C; Scully S; Tan HL; Xu W; Lacey DL; Boyle WJ; Simonet WS
Genes Dev; 1998 May; 12(9):1260-8. PubMed ID: 9573043
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
[TBL] [Abstract][Full Text] [Related]
9. [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)].
Inoue D
Nihon Rinsho; 2004 Feb; 62 Suppl 2():102-6. PubMed ID: 15035105
[No Abstract] [Full Text] [Related]
10. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno A; Amizuka N; Irie K; Murakami A; Fujise N; Kanno T; Sato Y; Nakagawa N; Yasuda H; Mochizuki S; Gomibuchi T; Yano K; Shima N; Washida N; Tsuda E; Morinaga T; Higashio K; Ozawa H
Biochem Biophys Res Commun; 1998 Jun; 247(3):610-5. PubMed ID: 9647741
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
Oshiro T; Shiotani A; Shibasaki Y; Sasaki T
Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development.
Vidal K; van den Broek P; Lorget F; Donnet-Hughes A
Pediatr Res; 2004 Jun; 55(6):1001-8. PubMed ID: 15155868
[TBL] [Abstract][Full Text] [Related]
13. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.
Cao J; Venton L; Sakata T; Halloran BP
J Bone Miner Res; 2003 Feb; 18(2):270-7. PubMed ID: 12568404
[TBL] [Abstract][Full Text] [Related]
14. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
Yamazaki H; Sasaki T
J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
[TBL] [Abstract][Full Text] [Related]
15. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
Salmon P
J Bone Miner Res; 2004 May; 19(5):695-702. PubMed ID: 15068491
[TBL] [Abstract][Full Text] [Related]
16. Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype.
Yamashita T; Okada S; Higashio K; Nabeshima Y; Noda M
Endocrinology; 2002 Dec; 143(12):4711-7. PubMed ID: 12446599
[TBL] [Abstract][Full Text] [Related]
17. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
Wada N; Maeda H; Yoshimine Y; Akamine A
Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
[TBL] [Abstract][Full Text] [Related]
19. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong YY; Feige U; Sarosi I; Bolon B; Tafuri A; Morony S; Capparelli C; Li J; Elliott R; McCabe S; Wong T; Campagnuolo G; Moran E; Bogoch ER; Van G; Nguyen LT; Ohashi PS; Lacey DL; Fish E; Boyle WJ; Penninger JM
Nature; 1999 Nov; 402(6759):304-9. PubMed ID: 10580503
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Nakamura M; Udagawa N; Matsuura S; Mogi M; Nakamura H; Horiuchi H; Saito N; Hiraoka BY; Kobayashi Y; Takaoka K; Ozawa H; Miyazawa H; Takahashi N
Endocrinology; 2003 Dec; 144(12):5441-9. PubMed ID: 14500574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
